Whitebox Advisors’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-298,145
| Closed | -$358 | – | 373 |
|
2024
Q2 | $358 | Hold |
298,145
| – | – | ﹤0.01% | 315 |
|
2024
Q1 | $40.3K | Hold |
298,145
| – | – | ﹤0.01% | 140 |
|
2023
Q4 | $44K | Hold |
298,145
| – | – | ﹤0.01% | 114 |
|
2023
Q3 | $22.7K | Hold |
298,145
| – | – | ﹤0.01% | 141 |
|
2023
Q2 | $51.7K | Hold |
298,145
| – | – | ﹤0.01% | 158 |
|
2023
Q1 | $38.5K | Hold |
298,145
| – | – | ﹤0.01% | 252 |
|
2022
Q4 | $48.8K | Hold |
298,145
| – | – | ﹤0.01% | 415 |
|
2022
Q3 | $61K | Hold |
298,145
| – | – | ﹤0.01% | 545 |
|
2022
Q2 | $75K | Hold |
298,145
| – | – | ﹤0.01% | 529 |
|
2022
Q1 | $128K | Buy |
+298,145
| New | +$128K | ﹤0.01% | 572 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 836 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 489 |
|
2021
Q2 | – | Sell |
-33,333
| Closed | -$20K | – | 421 |
|
2021
Q1 | $20K | Buy |
+33,333
| New | +$20K | ﹤0.01% | 348 |
|